MAPT and Alzheimer disease: If both abnormal Aβ and tau pathology are observed, the individual can be assigned “Alzheimer’s disease”, and an individual can be biologically assigned as “Alzheimer’s and concomitant suspected non-Alzheimer’s pathologic change” when both Aβ abnormality and neurodegeneration are observed [8].